News

TWINSBURG, Ohio -- (BUSINESS WIRE) -- LJ Star Inc., the industry's leading provider of process observation equipment, announces it has made a strategic investment in Alphinity USA., Inc., a pioneer in developing innovative, single-use solutions for the biopharmaceutical manufacturing industry. The investment enables Alphinity USA to expand its product line and manufacturing capabilities further. It also supports LJ Star's strategy to grow and diversify its product and business portfolio to include disruptive new technologies and to position the company to participate in the fast-growing single-use market.

"We are excited to partner with Alphinity and to support its objective to quickly become a preferred solutions provider to the rapidly expanding biopharmaceutical industry."

Alphinity's patented PIXER® device is a new Polymorphic Pump Technology™ (PPT™) that combines a pump and mixer in a single unit. The PIXER's revolutionary single-use technology (SUT) design provides unusually precise and consistent fluid control, even at very low volumes and pressures. This is particularly critical in biopharmaceutical applications where processing operations require the transfer and mixing of living cells in a liquid medium to be done in a highly accurate manner and without harm to the biologics.

Michael Gagne, founder and CEO of Alphinity said, "We are thrilled to have LJ Star as an investor and partner in our mission to achieve abundance in medicine by solving supply bottlenecks and driving down the cost of manufacturing biopharmaceutical products. LJ Star's expertise in designing, manufacturing, and supplying engineered products used in biotechnology and pharmaceutical markets and their commitment to quality make them an ideal partner for us."

David Star, founder and CEO of LJ Star, has 30 years of experience as a product specialist and leading supplier to process manufacturing industries. "We are excited to partner with Alphinity and to support its objective to quickly become a preferred solutions provider to the rapidly expanding biopharmaceutical industry," said Star. With the investment, Star will be joining Alphinity's board of directors.

Read on Business Wire →